Correlation Between 23Andme Holding and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Kymera Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Kymera Therapeutics.
Diversification Opportunities for 23Andme Holding and Kymera Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Kymera is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Kymera Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 1.07 times more return on investment than Kymera Therapeutics. However, 23Andme Holding is 1.07 times more volatile than Kymera Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 306.00 in 23Andme Holding Co on October 20, 2024 and sell it today you would earn a total of 55.00 from holding 23Andme Holding Co or generate 17.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Kymera Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Kymera Therapeutics |
23Andme Holding and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Kymera Therapeutics
The main advantage of trading using opposite 23Andme Holding and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |